Fact CheckerSign in

NCT07109739Recruiting

Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function

Source: ClinicalTrials.gov · Last updated 25 Nov 2025

Brief summary (registry, in English)

This study will assess the dose-response effects of Inspiratory Muscle Strength Training (IMST) in adults with above-normal systolic blood pressure over a 6-week period.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
144 (estimated)
First submitted
31 Jul 2025
Start date
24 Oct 2025
Primary completion date
31 Mar 2027
Lead sponsor
University of Minnesota
NCT number
NCT07109739

What you commit to

  • Study type: Interventional
  • Planned participants: 144
  • From 24 Oct 2025 to the primary completion date, 31 Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Recent abdominal surgery or presence of an abdominal hernia.

Other illness

  • Self-report of history of cardiovascular disease, or conditions affecting the ear (e.g., ruptured eardrum).
  • Ruptured eardrum or any other condition of the ear.
  • Current respiratory conditions such as a cold, sinusitis, or respiratory tract infection (participants may be included once they recover from the respiratory condition).

Other

  • Asthma with very low symptom perception, frequent severe exacerbations, or abnormally low perception of dyspnea.
  • Markedly elevated left ventricular end-diastolic volume and pressure.
  • Female-Specific: Pregnant or planning to become pregnant during the study period.
  • Compliance: Unable or unwilling to comply with pre-visit restrictions (e.g., avoiding caffeine, alcohol, and exercise within specified hours before visits).

Who the study is looking for

  • Age ≥18 years
  • Resting SBP ≥120 mmHg as measured during screening 1 \& 2
  • Free from serious CV or metabolic diseases as identified by self-report and blood chemistry analysis.
  • No contraindications to IMST (recent abdominal surgery, ruptured eardrum, asthma with very low symptom perception, fractured ribs, or pneumothorax)
  • Language: English-speaking, with ability to comprehend study materials and instructions.
  • Pre-visit Compliance: Willing to comply with pre-visit instructions (avoiding food and caffeine ≥ 3 hours, vigorous exercise, alcohol, and non-prescribed medications ≥ 24 hours) prior to each measurement visit.
  • Lifestyle: Non-smokers (defined as self-report of not smoking cigarettes or vaping over the past year).

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Minnesota
Coordinator of this site? Confirm its status
MinneapolisUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.